Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 4.91B P/E - EPS this Y -0.80% Ern Qtrly Grth -
Income -113.8M Forward P/E 11.52 EPS next Y 21.50% 50D Avg Chg 7.00%
Sales 4.43B PEG 1.02 EPS past 5Y -14.64% 200D Avg Chg 3.00%
Dividend 3.00% Price/Book 1.02 EPS next 5Y 10.00% 52W High Chg -17.00%
Recommedations 2.00 Quick Ratio 0.87 Shares Outstanding 136.42M 52W Low Chg 18.00%
Insider Own 0.32% ROA 1.20% Shares Float 135.61M Beta 0.49
Inst Own 97.83% ROE -2.42% Shares Shorted/Prior 4.26M/4.37M Price 36.30
Gross Margin 35.93% Profit Margin -2.81% Avg. Volume 1,186,327 Target Price 35.67
Oper. Margin 4.22% Earnings Date Aug 2 Volume 868,674 Change -0.14%
About Perrigo Company plc

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Perrigo Company plc News
11/11/24 Perrigo (PRGO) International Revenue Performance Explored
11/08/24 Perrigo Third Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.11 profit in 3Q 2023)
11/07/24 Perrigo (NYSE:PRGO) Is Paying Out A Dividend Of $0.276
11/07/24 Perrigo Co PLC (PRGO) Q3 2024 Earnings Call Highlights: Strategic Savings and EPS Growth Amid ...
11/06/24 Perrigo's Q3 Earnings Fall Short of Estimates, Sales View Updated
11/06/24 /C O R R E C T I O N -- Perrigo Company plc/
11/06/24 Perrigo (PRGO) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
11/06/24 Perrigo (PRGO) Q3 Earnings and Revenues Lag Estimates
11/06/24 Perrigo: Q3 Earnings Snapshot
11/04/24 Perrigo to Report Q3 Earnings: Here's What to Expect
11/01/24 Perrigo Announces Quarterly Dividend
10/31/24 Analysts Estimate QuidelOrtho (QDEL) to Report a Decline in Earnings: What to Look Out for
10/30/24 Perrigo (PRGO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
10/23/24 Perrigo Company plc (PRGO): Leading OTC Health Products with Strong Growth in Infant Formula
10/23/24 Perrigo to Release Third Quarter 2024 Financial Results on November 6, 2024
10/15/24 WNBA Star Napheesa Collier Joins Team Opill® for Candid Conversations on Women's Health
09/26/24 Perrigo Announces Good Start® and Dr. Browns® Brand Partnership and Launch of Infant Formula Portfolio
09/17/24 PERRIGO ANNOUNCES THE CLOSING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY
09/13/24 Insider Sale: Director Katherine Doyle Sells 8,954 Shares of Perrigo Co PLC
09/12/24 PERRIGO ANNOUNCES THE PRICING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY
PRGO Chatroom

User Image MadelinesUsa Posted - 1 day ago

[$APLS $PRGO] LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

User Image 11thestate Posted - 1 day ago

$PRGO agreed to a $97M settlement with investors over claims regarding Mylan's purchase offer and financial issues. Even if the deadline has passed, if you bought $PRGO between April 21, 2015, and May 3, 2017, you can still file for payment here: https://11thestate.com/cases/perrigo-investor-settlement

User Image zman94 Posted - 1 day ago

https://seekingalpha.com/article/4738614-perrigo-company-great-combination-of-future-growth-with-a-low-valuation $PRGO

User Image ErmiaJi Posted - 5 days ago

😏🚀 MYNZ We know the date of the reverse split (RS) if there will be one, but possibly a Nasdaq extension will be granted. Last time it traded, 50 million and 19 million heavy shorts attacked. Now, it has huge credibility after the TMO partnership and the meeting. The company will decide by November 25th whether or not to do an RS based on Nasdaq's response. Anyway, after the RS, I'm not worried about what happens next. A $210 billion partner TMO signing a deal with a penny stock has never happened before. I will be loading heavy on Monday. This will go to the moon like the DRUG stock recently did. The price target (PT) is $50. The squeeze will be parabolic. $PRGO $FOLD

User Image 11thestate Posted - 1 week ago

$PRGO agreed to a $97M settlement with investors over claims regarding Mylan's purchase offer and financial issues. Even if the deadline has passed, if you bought $PRGO between April 21, 2015, and May 3, 2017, you can still file for payment here: https://11thestate.com/cases/perrigo-investor-settlement

User Image Baino7 Posted - 1 week ago

$PRGO Here for the wild swings and the .276 dividend. Eventually this will pop and my patience with this stock will be rewarded. In the meantime, I continue to stockpile bc it’s a Promising Company/Stock.

User Image Pika_Capital Posted - 2 weeks ago

$PRGO $PBH $IBRX $APLS anyone who tags MYNZ, report them viciously. Bots took over X platform. Hopefully ST will stop this nonsense. @Alyssa_CC

User Image dayandswing22 Posted - 2 weeks ago

$PRGO soon

User Image 11thestate Posted - 2 weeks ago

$PRGO agreed to a $97M settlement with investors over claims regarding Mylan's purchase offer and financial issues. Even if the deadline has passed, if you bought $PRGO between April 21, 2015, and May 3, 2017, you can still file for payment here: https://11thestate.com/cases/perrigo-investor-settlement

User Image OpenOutcrier Posted - 2 weeks ago

$PRGO (+1.1% pre) Perrigo Reports Third Quarter 2024 Financial Results From Continuing Operations https://ooc.bz/l/47048

User Image DonCorleone77 Posted - 2 weeks ago

$PRGO Perrigo backs FY24 adjusted EPS view $2.50-$2.65, consensus $2.56 The company said, "The Company expects its fiscal 2024 organic net sales and total net sales outlook to be towards the lower end of their previously stated ranges of organic net sales growth outlook versus the prior year of -3% to -1% and total net sales growth outlook versus the prior year of -5% to -3%. The Company reaffirms its adjusted diluted EPS outlook of $2.50 to $2.65. "

User Image DonCorleone77 Posted - 2 weeks ago

$PRGO Perrigo reports Q3 adjusted EPS 81c, consensus 81c Reports Q3 revenue $1.09B, consensus $1.12B. President and CEO, Patrick Lockwood-Taylor commented, "During the third quarter, we made significant progress to advance our One Perrigo vision by stabilizing core businesses, investing in World-Class CPG capabilities and leadership, and executing with excellence against our accretive initiatives."

User Image dayandswing22 Posted - 2 weeks ago

$PRGO

User Image 11thestate Posted - 10/30/24

$PRGO agreed to a $97M settlement with investors over claims regarding Mylan's purchase offer and financial issues. Even if the deadline has passed, if you bought $PRGO between April 21, 2015, and May 3, 2017, you can still file for payment here: https://11thestate.com/cases/perrigo-investor-settlement

User Image Broview Posted - 10/30/24

$PRGO keep beating estimates?

User Image MVSTACKS Posted - 10/28/24

$PRGO what’s cookin here?

User Image dayandswing22 Posted - 10/25/24

$PRGO should have known when those JP Morgan crooks issued an upgrade that it was so they could dump shares on retail

User Image dayandswing22 Posted - 10/25/24

$PRGO so everyday this shit is just going to sell off for no reason? Rigged. Holding

User Image 11thestate Posted - 10/23/24

$PRGO agreed to a $97M settlement with investors over claims regarding Mylan's purchase offer and financial issues. Even if the deadline has passed, if you bought $PRGO between April 21, 2015, and May 3, 2017, you can still file for payment here: https://11thestate.com/cases/perrigo-investor-settlement

User Image DonCorleone77 Posted - 10/22/24

$PRGO Giveaway season before elections continues: Biden admin proposes free OTC birth control, contraceptives, Reuters says The Biden administration is proposing a rule that would provide women with private insurance access to over-the-counter, OTC, birth control pills and contraceptives at no cost, Ahmed Aboulenein of Reuters reports. This rule will expand a federal mandate requiring health insurers to cover preventative care services at no cost under the Affordable Care Act, is being proposed by the Departments of Health and Human Services, Labor, and the Treasury, and, if finalized, would come into effect in 2025. Currently, Perrigo's Opill is the only daily birth control pill approved for sale without a prescription by the U.S. FDA, but the proposed rule covers other forms of contraceptives, including emergency contraception, spermicides, birth control sponges, and condoms.

User Image OptionRunners Posted - 1 month ago

$PRGO Trader sold the November 15th $30 calls 5,000 times for $0.42 and bought the November 15th $27.50 calls 5,000 times for $1.09. The trader is rolling the calls down for a net debit of $0.67 More bullish flow in $PRGO today. The $25 calls are still in the OI up to $2.25 now.

User Image Kher33 Posted - 1 month ago

$PRGO https://www.cnn.com/2024/10/21/politics/biden-administration-contraception-proposal/index.html

User Image OptionRunners Posted - 1 month ago

$PRGO strong early on again. Calls trading $2.15 now

User Image JackDarwin Posted - 1 month ago

$PRGO Bullish Engulfing Formed At Downtrend. https://www.stockaio.com/US/ai/Stock/PRGO/Candlestick

User Image swingingtech Posted - 1 month ago

$RYTM $AA $PRGO https://wallstreetwaves.com/significant-thursday-options-trading-insights-rytm-aa-prgo/

User Image ShortingTheTrend Posted - 1 month ago

$PRGO MACD cross up and RSI is low, I think $29.50 is very possible... I think this is the bottom

User Image ShortingTheTrend Posted - 1 month ago

$PRGO grabbed one

User Image ShortingTheTrend Posted - 1 month ago

$PRGO $26.98 let's goooo

User Image Coolidge87 Posted - 1 month ago

$BIIB $PRGO $PGNY $CRSP $ALGN Healthcare stocks with good potential.

User Image OptionRunners Posted - 1 month ago

$PRGO Buyer of the November 15th $25 calls 8,000 times for $1.20-$1.35

Analyst Ratings
Canaccord Genuity Buy Sep 30, 24
Jefferies Hold Sep 23, 24
Piper Sandler Overweight Jul 11, 24
Piper Sandler Overweight Jun 13, 24
Canaccord Genuity Buy Apr 12, 24
Piper Sandler Overweight Apr 8, 24
JP Morgan Overweight Feb 28, 24
Piper Sandler Overweight Nov 17, 23
JP Morgan Overweight Aug 9, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Willis Robert EVP & CHRO EVP & CHRO Nov 24 Buy 31.01 5,550 172,106 19,105 11/27/23
Ives Alison EVP & Chief Scientif.. EVP & Chief Scientific Officer Nov 16 Buy 29.34 2,040 59,854 10,380 11/17/23
Ives Alison EVP & Chief Scientif.. EVP & Chief Scientific Officer Oct 06 Option 30.46 738 22,479 9,078 10/10/23
Manzone Albert Director Director Aug 15 Option 38.88 5,478 212,985 5,478 08/17/23
Ives Alison EVP & Chief Scientif.. EVP & Chief Scientific Officer Jul 07 Option 32.63 920 30,020 8,611 07/10/23
HANSON KYLE EVP & General Counse.. EVP & General Counsel Jul 07 Option 32.63 12,409 404,906 9,552 07/10/23
Parker Geoffrey M. Director Director Jun 13 Buy 33.0637 10,000 330,637 25,879 06/14/23
Andersen Svend EVP & President CHCI EVP & President CHCI May 23 Buy 33.4146 2,900 96,902 68,741 05/25/23
KESSLER MURRAY S CEO CEO May 11 Sell 35.7526 197,646 7,066,358 2,668 05/15/23
Dillard James E III EVP & President CSCA EVP & President CSCA Mar 10 Sell 35.701 9,000 321,309 25,130 03/14/23
Farrington Thomas EVP and CIO EVP and CIO Mar 13 Sell 35.58 3,723 132,464 2,823 03/14/23
Ives Alison EVP & Chief Scientif.. EVP & Chief Scientific Officer Mar 07 Option 37.71 1,746 65,842 8,201 03/09/23
Farrington Thomas EVP and CIO EVP and CIO Mar 06 Option 37.71 2,406 90,730 7,705 03/08/23
Parker Geoffrey M. Director Director Mar 06 Buy 38.054 5,000 190,270 15,879 03/07/23
Quinn Grainne EVP, Chief Medical O.. EVP, Chief Medical Officer Dec 16 Sell 31.65 2,368 74,947 9,118 12/20/22
Karaboutis Adriana Director Director May 17 Option 38.57 6,599 254,523 17,046 05/19/22
Doyle Katherine C. Director Director May 17 Option 38.57 6,599 254,523 9,530 05/19/22
O'Connor Donal Director Director May 17 Option 38.57 6,599 254,523 20,054 05/19/22
Mann Erica L Director Director May 17 Option 38.57 6,599 254,523 12,289 05/19/22
ASHFORD ORLANDO D Director Director May 17 Option 38.57 6,599 254,523 8,150 05/19/22
Samuels Theodore R. II Director Director May 17 Option 38.57 6,599 254,523 26,693 05/19/22
Alford Bradley A Director Director May 17 Option 38.57 6,599 254,523 30,577 05/19/22
Parker Geoffrey M. Director Director May 17 Option 38.57 6,599 254,523 14,829 05/19/22
KINDLER JEFFREY B Director Director May 17 Option 38.57 6,599 254,523 17,574 05/19/22
SILCOCK RAYMOND EVP, Chief Financial.. EVP, Chief Financial Officer Apr 05 Option 36.27 3,963 143,738 60,955 04/07/22
Farrington Thomas EVP and CIO EVP and CIO Mar 14 Sell 37.18 26,744 994,342 03/16/22
Willis Robert EVP & CHRO EVP & CHRO Mar 04 Option 37.23 5,012 186,597 9,760 03/08/22
Janish Ronald Craig EVP, Gbl Ops & SC &.. EVP, Gbl Ops & SC & CTO Mar 04 Option 37.23 5,410 201,414 20,559 03/08/22
Janish Ronald Craig EVP, Gbl Ops & SC &.. EVP, Gbl Ops & SC & CTO Mar 04 Sell 36.73 3,954 145,230 15,686 03/08/22
Farrington Thomas EVP and CIO EVP and CIO Mar 04 Option 37.23 4,424 164,706 25,185 03/08/22
ASHFORD ORLANDO D Director Director Mar 04 Option 37.23 2,984 111,094 2,984 03/08/22
KINGMA TODD W Executive VP, Genera.. Executive VP, General Counsel Mar 04 Option 37.23 8,911 331,757 46,677 03/08/22
Dillard James E III EVP & President CSCA EVP & President CSCA Mar 04 Option 37.23 7,002 260,684 24,148 03/08/22
Quinn Grainne EVP, Chief Medical O.. EVP, Chief Medical Officer Mar 04 Option 37.23 3,862 143,782 12,310 03/08/22
KESSLER MURRAY S CEO CEO Mar 04 Option 37.23 49,328 1,836,481 127,489 03/08/22
SILCOCK RAYMOND EVP, Chief Financial.. EVP, Chief Financial Officer Mar 04 Option 37.23 8,502 316,529 58,796 03/08/22
Andersen Svend EVP & President CHCI EVP & President CHCI Mar 04 Option 37.23 8,911 331,757 41,372 03/08/22
Dillard James E III EVP & President CSCA EVP & President CSCA Feb 07 Option 36.95 4,297 158,774 14,900 02/09/22
KESSLER MURRAY S CEO CEO Mar 09 Option 41.04 30,446 1,249,504 49,164 03/09/21
Kochan Sharon EVP & President Rx EVP & President Rx Mar 09 Option 41.04 4,057 166,499 38,748 03/09/21
Sorota Richard S EVP & President CSCA EVP & President CSCA Mar 09 Option 41.04 2,540 104,242 10,053 03/09/21
Farrington Thomas EVP and CIO EVP and CIO Mar 09 Option 41.04 2,730 112,039 18,468 03/09/21
Dillard James E III EVP, Chief Scientifi.. EVP, Chief Scientific Officer Mar 09 Option 41.04 4,322 177,375 11,173 03/09/21
Willis Robert EVP & CHRO EVP & CHRO Mar 09 Option 41.24 2,780 114,647 4,788 03/09/21
Quinn Grainne EVP, Chief Medical O.. EVP, Chief Medical Officer Mar 09 Option 41.04 2,279 93,530 7,299 03/09/21
Janish Ronald Craig EVP, Gbl Ops & SC &.. EVP, Gbl Ops & SC & CTO Mar 09 Option 41.04 3,339 137,033 14,835 03/09/21